Virtual Library

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

Filter Results:

Show Only Available Presentations

  • +

    P1.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 87
    • Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P1.01-082 - A Phase III Study of MEDI4736 (M) an Anti-PD-L1 Antibody ± Tremelimumab (T), vs Standard of Care (SoC), in Patients with Advanced NSCLC (ARCTIC)

      09:30 - 09:30  |  Author(s): D. Planchard

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 06 - Next Generation Sequencing and Testing Implications

    • Type: Oral Session
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 9
    • Moderators:G. De Lima Lopes
    • Coordinates: 9/07/2015, 10:45 - 12:15, Mile High Ballroom 1a-1f
    • +

      ORAL06.03 - Genome-Wide Gene Copy Number Analysis by OncoScanTM FFPE Assay in 976 Resected NSCLC From LACE-Bio2

      11:27 - 11:38  |  Author(s): M.S. Tsao

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL06.05 - Molecular Tumor Board (MTB) in Non-Small Cell Lung Cancers (NSCLC) to Optimize Targeted Therapies: 4 Years' Experience at Gustave Roussy

      11:48 - 11:59  |  Author(s): D. Planchard

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 03 - PD1 Axis Inhibition and EGFR

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 11
    • Moderators:L. Gandhi
    • Coordinates: 9/07/2015, 16:45 - 18:15, Four Seasons Ballroom F1+F2
  • +

    ORAL 16 - Clinical Care of Lung Cancer and Advanced Biopsies

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 8
    • Moderators:J.W. Neal
    • Coordinates: 9/08/2015, 10:45 - 12:15, Mile High Ballroom 2a-3b
    • +

      ORAL16.05 - Retrospective Analysis of ctDNA EGFR Mutations in the Phase III, Randomized IMPRESS Study

      11:28 - 11:39  |  Author(s): S. Kim

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 17 - EGFR Mutant Lung Cancer

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 9
    • Moderators:P. Meldgaard
    • Coordinates: 9/08/2015, 10:45 - 12:15, Four Seasons Ballroom F3+F4
    • +

      ORAL17.08 - Gefitinib/Chemotherapy vs Chemotherapy in EGFR Mutation-Positive NSCLC Resistant to First-Line Gefitinib: IMPRESS T790M Subgroup Analysis

      12:01 - 12:12  |  Author(s): J. Soria

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 16 - EGFR Mutant Lung Cancer 2

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:G.J. Riely
    • Coordinates: 9/08/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
  • +

    MINI 25 - Trials, Radiation and Other

    • Type: Mini Oral
    • Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
    • Presentations: 15
    • Moderators:J.M. Clavero
    • Coordinates: 9/08/2015, 16:45 - 18:15, 702+704+706
  • +

    PLEN 03 - Science Drives Lung Cancer Advances

    • Type: Plenary
    • Track: Plenary
    • Presentations: 6
    • Moderators:T. Mitsudomi
    • Coordinates: 9/09/2015, 08:15 - 09:45, Plenary Hall (Bellco Theatre)
  • +

    ORAL 32 - EGFR WT and MT Targeting

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 8
    • Moderators:K.J. O'Byrne
    • Coordinates: 9/09/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
    • +

      ORAL32.01 - Tumor Genomic Analysis from LUX-Lung 8: A Phase III Trial of Afatinib versus Erlotinib in Squamous Cell Carcinoma of the Lung

      16:45 - 16:56  |  Author(s): J. Soria

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.